Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 1,004 | 855 | 2,659 | 754 | 837 |
| Gross Profit | 1,004 | 855 | 2,659 | 754 | 837 |
| Operating Expenses | 1,506 | 1,791 | 2,931 | 1,483 | 1,290 |
| Operating Income | -502 | -936 | -272 | -729 | -453 |
| Other Income | 18 | 26 | 26 | 27 | 25 |
| Pre-tax Income | -484 | -910 | -246 | -702 | -429 |
| Income Tax | N/A | 0 | 8 | -162 | -46 |
| Net Income Continuous | -484 | -910 | -254 | -541 | -382 |
| Net Income | $-484 | $-910 | $-254 | $-541 | $-382 |
| EPS Basic Total Ops | -0.08 | -0.15 | -0.04 | -0.09 | -0.06 |
| EPS Basic Continuous Ops | -0.08 | -0.15 | -0.04 | -0.09 | -0.06 |
| EPS Diluted Total Ops | -0.08 | -0.15 | -0.04 | -0.09 | -0.06 |
| EPS Diluted Continuous Ops | -0.08 | -0.15 | -0.04 | -0.09 | -0.06 |
| EBITDA(a) | $-493 | $-946 | $-262 | $-719 | $-444 |